Sunday 25 October |
1000 – 1130 | CH1: Plenary session 2: Past, present and future of rheumatology
Chairpersons:
Syed Atiqul Haq and Yoshiya Tanaka
Speakers:
Rheumatology: A Crystal Gaze? – a future perspective
Syed Atiqul Haq, BSM Medical University
Two decades of progress in rheumatology – what have we learnt?
Iain McInnes, University of Glasgow |
1130 – 1245 | CH2: Morning symposium 5
Treatment of Rheumatoid Arthritis: Past and Future
Speakers:
Masaru Kato
Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University | CH3: Morning symposium 6
To continue, taper or discontinue biologics – Implications on RA treatment outcomes
Chairpersons:
Professor Yoshiya Tanaka
University of Occupational and Environmental Health, Kitakyushu, JAPAN
Speakers:
Associate Professor Peter Nash
Department of Medicine / University of Queensland, Brisbane, AUSTRALIA
Associate Professor Khoa Dinh Nguyen
Cho Ray Hospital, Ho Chi Minh City, VIETNAM
Professor Wen-Chan Tsai
Kaohsiung Medical University Hospital, Kaohsiung, TAIWAN
| CH4: Morning symposium 7
Denosumab, anti-RANKL antibody, for the treatment of joint destruction in RA. − From DRIVE & DESIRABLE studies
Chairpersons:
Professor Tatsuya Atsumi
Professor of Medicine in the Faculty of Medicine / Hokkaido University
Speakers:
Professor Tsutomu Takeuchi
Professor of Rheumatology, Department of Internal Medicine/Keio University School of Medicine | |
| Brought to you by  | Brought to you by  | Brought to you by
 | |
1245 – 1315 | Break |
1315 – 1445 | CH1: Lunch symposium 3
New insights for clinical practice in Spondyloarthritis, SpA
Chairpersons:
Associate Professor Yuko Kaneko
Associate Professor, Division of Rheumatology and Department of Internal Medicine/Keio University School of Medicine
Professor Naoto Tamura
Professor and Chairman, Department of Internal Medicine and Rheumatology/Juntendo University School of Medicine
Speakers:
Dr Kei Ikeda
Senior Lecturer, Department of Allergy and Clinical Immunology/Chiba University Hospital
Dr Kenta Misaki
Chief Director, Department of Rheumatology/Kita-Harima Medical Center
Professor Yuho Kadono
Chief Administrator, Orthopedic Surgery/Saitama Medical University
Brought to you by
 | CH2: Lunch symposium 4
Innovative therapeutic alternatives for RA, PsA, AS and nr-axSpA: Individualising the treatment approach
Chairperson:
Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan
Speakers:
Dr Kunihiro Yamaoka
Division of Rheumatology, Kitasato University Hospital, Japan
Professor Lars Erik Kristensen
Parker Institute / University Copenhagen
Professor Andrew Ostör
Cabrini Medical Centre / Emeritus Research
Brought to you by
 |
1445 – 1500 | Break |
1500 – 1640 | CH1: Merge of Basic and Clinical research in Vascultic disorders | CH2: SLE – 2: SLE clinical | CH3: Genetics: recent progress in genetics of rheumatic diseases | CH4: SpA – 2: Updates in PsA |
Chairpersons:
Debashish Danda, Xinping Tian and Masayoshi Harigai | Chairpersons:
Yoshiya Tanaka | Chairpersons:
Michael Tee and Zhanghou Li | Chairpersons:
Atimichi Morita and James Wei |
Section 1: Update on vasculitis |
Recent advances in AAV
Tony Sammel, Prince of Wales and Sydney Eye Hospitals | Management of systemic lupus erythematosus (SLE) during and beyond the COVID-19 pandemic
Sandra V. Navarra, University of Santo Tomas | GWAS, eQTL and epigenome of rheumatic diseases
Kazuhiko Yamamoto, RIKEN Center for Integrative Medical Sciences | Differential diagnosis of Psoriatic arthritis in daily practice
Mitsumasa Kishimoto, Kyorin University School of Medicine |
Behcet’s disease – what is new?
Thurayya Arayssi, Weill Cornell Medicine |
Genetic analysis of Takayasu arteritis
Ruchika Goel, Christian Medical College |
Panel Q&A | Continuing challenges in lupus nephritis
Daniel TM Chan, University of Hong Kong | Genetics of Kawasaki Disease: where are we in circa 2020
Surjit Singh, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education And Research, Chandigarh | Risk assessment and prevention of cardiovascular co-morbidities in psoriatic arthritis
Lai-Shan Tam, The Chinese University of Hong Kong |
Section 2: APLAR Vascuilitis clinic – recent trends |
Evaluation of large vessel vasculitis
Takahiko Sugihara, Tokyo Medical and Dental University |
New trials with repurposed drugs in Takayasu arteritis
Xinping Tian, Peking Union Medical College Hospital |
GCA and PMR in Australia: evolving treatment paradigms and clinical research
David Liew, Austin Health | Special issues on pregnancy and lactation
Aisha Lateef, Woodlands Health Campus | Genetic risk score
Sarah Reid | Biomarker for PsA – myth or reality
Katy Leung, Singapore General Hospital, Duke-nus Medical School |
Current key areas in futuristic ‘state of the art’ vasculitis research
Masayoshi Harigai, Tokyo Women’s Medical University | Treatment update of PsA
Peter Nash, Griffith University |
Panel Q&A |
SECTION 3: Beginners research on vasculitic diseases |
Panel discussion by young researchers
Carotid Doppler in Takayasu Arteritis
Kyaw Thura Zaw
GCA research in Adelaide
Jem Ninan
Suggestions on research in resource limited set up
Debashish Danda | Panel Q&A | Panel Q&A | Panel Q&A |
1640 – 1740 | CH1: Abstract session: IIM, SSc, SjS | CH2: Abstract session: SLE and APL syndrome 2 | CH3: Abstract session: OA and Crystal induced arthritis | CH4: Abstract session: SpA, AS-1 |
Chairperson:
Layla Kazkaz | Chairperson:
Yoshiya Tanaka | Chairperson:
TBA | Chairperson:
Mitsumasa Kishimoto |
Clinical Responses to Low-dose Interleukin-2 in Idiopathic Inflammatory Myopathies
Miao Miao, Peking University People’s Hospital | Leukocyte immunoglobulin-like receptor A3 (LILRA3) promotes lupus-like disease severity
Yundi Tang, Peking University People’s Hospital | The numeral changes of peripheral lymphocyte subsets in 238 patients with GOUT and their correlation analysis with disease activity
Lijun Zhao, The Second Hospital of Shanxi Medical University | Efficacy and Safety of Brodalumab, Anti-IL-17 Receptor A Monoclonal Antibody, for Axial Spondyloarthritis, A 68-Week Result of Phase 3 Study
James Wei |
Prediction of myocardial abnormalities in systemic sclerosis, assessed in cardiac magnetic resonance imaging, by using artificial neural networks models
Masaki Haraoka, St. Marianna University School of Medicine | Should ophthalmologic evaluation be done as a screening test for new onset lupus patients with no eye complaint?
Seyedeh Tahereh Faezi, Tehran University of Medical Sciences | Subtype Genome-Wide Meta-Analyses of Clinically-Defined Gout Revealed Multiple Subtype-Specific Gout Loci and Enrichment of Selection Pressure on ABCG2 and ALDH2
Yusuke Kawamura, National Defense Medical College | Improvements in Patient-Reported Outcomes in AS Patients Treated With Golimumab: Sub-Analysis of Asian Patients Enrolled in Phase III Clinical Trials
Wen-Chan Tsai, Kaohsiung Medical University |
Clinical analysis of dermatomyositis / polymyositis / cancer-associated myositis and related research on peripheral blood CD4 + T lymphocyte subsets
Pan-di Zhang, The Second Hospital of Shanxi Medical University | Long-term Remission in Systemic Lupus Erythematosus
Alireza Khabbazi, Connective Tissue Diseases Research Center | Systematic Review and Meta-Analysis of the Prevalence of Neuropathic-Like Pain and Pain Sensitisation in People With Knee and Hip Osteoarthritis
Luigi Zolio, Alfred Health | Abnormality of peripheral lymphocyte subsets in patients with ankylosing spondylitis and restoration after receiving immunoregulatory combination therapies
Shengxiao Zhang, The Second Hospital of Shanxi Medical University |
Diagnostic Accuracy of Salivary Free Light Chain and Immunoglobulin Assays in Primary Sjögren’s Syndrome
Pulukool Sandhya, St Stephens Hospital Delhi | Voclosporin Has Demonstrated Efficacy in Asian Patients With Lupus Nephritis
Tatsuya Atsumi, Hokkaido University | A Randomised Placebo-controlled Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-synovitis of Knee Osteoarthritis (CurKOA trial)
Benny Samuel Eathakkattu Antony, University of Tasmania | Comorbidity Profiles among patients with Axial Spondyloarthritis
Fariz Yahya |
The Artificial Intelligence for the Prediction of Focal Score of Labial Salivary Gland Biopsy in the Diagnosis of Sjogren Syndrome
Noboru Kitamura, Nihon University School of Medicine | Newly Diagnosed Lupus Nephritis in Elderly Predicts Good Renal Outcome: a Distinct Disease Subset from Young-onset Lupus Nephritis
Kazuoto Hiramoto, Keio University School of Medicine | The Trajectory of Exercise Adherence Over Time and the Effect of Theory-lead Intervention for Knee Osteoarthritis in Elderly
Limin Wang, Peking University | Response to Certolizumab Pegol in Patients with Non-Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Cut-Offs: Post-Hoc Analysis from C-axSpAnd
Philip Robinson, University of Queensland |
Effects of Nintedanib in Asian Patients with Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD): Subgroup Analysis of the SENSCIS Trial
Masataka Kuwana, Nippon Medical School | Thrombotic risk assessment in patient with systemic lupus erythematosus: validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients
Wanitcha Chanloung, Chiang Mai University | The Prevalence and Incidence of Symptom Knee Osteoarthritis in the Middle-aged and Elderly: a National Survey from China
Limin Wang, Peking University | Imbalance of Th17/Treg In Cardiovascular Diseases of Patients With Ankylosing Spondylitis
Tingting Ding, The Second Hospital of Shanxi Medical University |
Joint Q&A | Joint Q&A | Prevalence and Clinical Features of Early-onset Osteoarthritis in a Large Scale Cross-sectional Study
Jiajing Peng, Peking University People’s Hospital | Joint Q&A |
Joint Q&A |
1740 – 1840 | CH1: Evening symposium 5
Addressing Unmet Needs in RA and PsA: The Right Drug for the Right Patient
Chairpersons:
Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine
Speakers:
Professor Yoshiya Tanaka
Professor and Chairman of the First Department of Internal Medicine / School of Medicine,
University of Occupational and Environmental Health
Professor Filip Van den Bosch
Professor of Rheumatology and Head-of-Clinic,
Department of Rheumatology
/ University Hospital of Ghent University
Professor Tsutomu Takeuchi
Professor of Rheumatology,
Department of Internal Medicine/Keio University School of Medicine
| CH2: Evening symposium 6
Evolution of interleukin-6 inhibiting therapies for rheumatoid arthritis
Chairpersons:
Dr Yutaka Kawahito M.D., Ph.D.
Head of the Department of Inflammation and Immunology/Kyoto Prefectural University of Medicine
Speakers:
Professor Motomu Hashimoto
Department of Advanced Medicine for Rheumatic Diseases, Kyoto University.
|
| Brought to you by
 | Brought to you by
 |